Analysts Conflicted on These Healthcare Names: Cartesian Therapeutics (RNAC), Insmed (INSM) and BioNTech SE (BNTX)
TipRanksApr 23 18:40
HC Wainwright & Co. : The BioNTech (BNTX.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $107.00.
Zhitong FinanceApr 17 18:30
BioNTech Analyst Ratings
BenzingaApr 17 18:20
HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $107 Price Target
BenzingaApr 17 18:24
Analysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB)
TipRanksApr 17 18:20
BioNTech Analyst Ratings
BenzingaMar 28 02:12
UBS Cuts BioNTech Price Target to $101 From $110, Maintains Neutral Rating
MT NewswiresMar 27 21:23
Optimistic Outlook for BioNTech: A Buy Rating Amidst Vaccine Demand and Strong Oncology Pipeline
TipRanksMar 25 09:26
BioNTech Analyst Ratings
BenzingaMar 23 00:35
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Intuitive Surgical (ISRG) and Bolt Biotherapeutics (BOLT)
TipRanksMar 22 18:21
BMO Capital Maintains Outperform on BioNTech, Lowers Price Target to $123
BenzingaMar 22 01:21
TD Cowen Adjusts BioNTech Price Target to $95 From $101, Maintains Market Perform Rating
MT NewswiresMar 22 00:08
BioNTech Analyst Ratings
BenzingaMar 21 23:32
Hold Rating for BioNTech: Navigating Vaccine Revenue Decline and Prospective Oncology Pipeline
TipRanksMar 21 22:35
Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Edwards Lifesciences (EW) and Innovent Biologics (OtherIVBXF)
TipRanksMar 21 20:01
Analysts Are Bullish on Top Healthcare Stocks: Femasys (FEMY), BioNTech SE (BNTX)
TipRanksMar 21 18:31
Maintaining Hold on BioNTech: A Balancing Act Between Near-Term Challenges and Long-Term Oncology Investment
TipRanksMar 21 09:05
Jefferies Keeps Their Hold Rating on BioNTech SE (BNTX)
TipRanksMar 21 05:55
UBS Keeps Their Hold Rating on BioNTech SE (BNTX)
TipRanksMar 20 22:05
BioNTech Analyst Ratings
BenzingaFeb 23 19:28
No Data
No Data